
SCI Pharmtech, Inc.
TWSE:4119.TW
Overview | Financials
Company Name | SCI Pharmtech, Inc. |
Symbol | 4119.TW |
Currency | TWD |
Price | 88.2 |
Market Cap | 10,540,693,800 |
Dividend Yield | 0.27% |
52-week-range | 82.5 - 98.5 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Wen-Chih Chou |
Website | https://www.sci-pharmtech.com.tw |
An error occurred while fetching data.
About SCI Pharmtech, Inc.
SCI Pharmtech, Inc. engages in the research and development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and specialty chemicals. Its active pharmaceutical ingredients include Articaine HCl, Atomoxetine HCl, Bisoprolol Fumarate, Brinzolamide, Divalproex Sodium, Duloxetine HCl, Hydroxychloroquine sulfate, Loxoprofen Sodium, Methylphenidate HCl, Pentobarbital Sodium, Probucol, Propafenone HCl, Sodium Valproate,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD